Published in J Bone Miner Res on May 01, 2015
Macrophages: Their Emerging Roles in Bone. J Bone Miner Res (2015) 0.88
Chemotherapy- and irradiation-induced bone loss in adults with solid tumors. Curr Osteoporos Rep (2015) 0.79
Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources. Bone Marrow Transplant (2016) 0.79
Hematopoiesis "awakens": Evolving technologies, the force behind them. Exp Hematol (2015) 0.75
Early changes in bone mineral density and trabecular bone score following allogeneic stem cell transplant. Bone Marrow Transplant (2016) 0.75
Ciliary neurotrophic factor has intrinsic and extrinsic roles in regulating B cell differentiation and bone structure. Sci Rep (2015) 0.75
Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. FASEB J (2017) 0.75
The skeletal impact of the chemotherapeutic agent etoposide. Osteoporos Int (2017) 0.75
A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med (2009) 11.20
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2010) 6.00
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2013) 5.76
A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell (2007) 4.59
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet (2005) 3.98
Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell (2007) 3.82
The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy. Blood (2010) 3.23
Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust (2012) 3.14
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab (2012) 2.87
Clinical studies of histone deacetylase inhibitors. Clin Cancer Res (2009) 2.68
Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study. J Clin Oncol (2012) 2.65
MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci U S A (2010) 2.53
Is high dose vitamin D harmful? Calcif Tissue Int (2012) 2.43
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev (2010) 2.38
Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes (2009) 2.34
Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways. Proc Natl Acad Sci U S A (2008) 2.15
Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis (2008) 2.10
Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment. Blood (2011) 1.96
Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol (2005) 1.85
Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice. J Clin Invest (2008) 1.81
Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia. Blood (2011) 1.69
A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma. Blood (2011) 1.69
Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care (2011) 1.67
Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Med J Aust (2002) 1.59
EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone. J Bone Miner Res (2013) 1.55
Association of cartilage defects with loss of knee cartilage in healthy, middle-age adults: a prospective study. Arthritis Rheum (2005) 1.49
The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review. Leuk Lymphoma (2014) 1.47
Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab (2012) 1.45
Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf) (2012) 1.43
Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res (2011) 1.40
Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol (2010) 1.39
Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia. Leuk Lymphoma (2008) 1.38
Irreducible anterior dislocation of the shoulder due to soft tissue interposition of subscapularis tendon. Skeletal Radiol (2007) 1.37
A pictorial review of primary synovial osteochondromatosis. Eur Radiol (2008) 1.32
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma. Br J Haematol (2009) 1.28
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation. Gene (2006) 1.28
53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis. Proc Natl Acad Sci U S A (2006) 1.27
Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Clin Cancer Res (2012) 1.26
GP130 cytokines and bone remodelling in health and disease. BMB Rep (2010) 1.23
14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol (2010) 1.20
Generation and analysis of Siah2 mutant mice. Mol Cell Biol (2003) 1.15
Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. PLoS One (2012) 1.14
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy. Br J Haematol (2010) 1.12
Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. Proc Natl Acad Sci U S A (2014) 1.10
What is the true nature of the osteoblastic hematopoietic stem cell niche? Trends Endocrinol Metab (2009) 1.09
Approach to the patient with secondary osteoporosis. Eur J Endocrinol (2010) 1.08
Gsα enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice. J Clin Invest (2011) 1.08
Routine screening for vitamin D deficiency in early pregnancy: past its due date? Med J Aust (2011) 1.08
Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum (2012) 1.08
Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood (2008) 1.07
Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency. J Bone Miner Res (2008) 1.05
Bizarre parosteal osteochondromatous proliferation: a locally aggressive benign tumor. Clin Orthop Relat Res (2011) 1.04
Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT. J Clin Endocrinol Metab (2013) 1.04
Tumor ablation by gene-modified T cells in the absence of autoimmunity. Cancer Res (2010) 1.04
Intercellular cross-talk among bone cells: new factors and pathways. Curr Osteoporos Rep (2012) 1.03
Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies. Haematologica (2005) 1.02
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program. Proc Natl Acad Sci U S A (2011) 1.02
Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskelet Disord (2008) 1.02
Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA. Bone (2013) 1.01
Reduced genetic variation occurs among genes of the highly clonal plant pathogen Xanthomonas axonopodis pv. vesicatoria, including the effector gene avrBs2. Appl Environ Microbiol (2005) 1.00
The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf) (2003) 0.99
Graft-versus-lymphoma effects: clinical review, policy proposals, and immunobiology. Biol Blood Marrow Transplant (2004) 0.99
Central abdominal fat and endogenous hormones during the menopausal transition. Fertil Steril (2003) 0.98
ATM substrate Chk2-interacting Zn2+ finger (ASCIZ) Is a bi-functional transcriptional activator and feedback sensor in the regulation of dynein light chain (DYNLL1) expression. J Biol Chem (2011) 0.98
Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells. Haematologica (2013) 0.97
In vivo tracking of dendritic cells in patients with multiple myeloma. J Immunother (2008) 0.96
An atypical subtrochanteric femoral fracture from pycnodysostosis: a lesson from nature. J Bone Miner Res (2011) 0.96
Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One (2013) 0.96
Effects of a targeted multimodal exercise program incorporating high-speed power training on falls and fracture risk factors in older adults: a community-based randomized controlled trial. J Bone Miner Res (2014) 0.95
Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma. Leuk Lymphoma (2007) 0.95
Identification of the molecular requirements for an RAR alpha-mediated cell cycle arrest during granulocytic differentiation. Blood (2003) 0.94
Effect of vitamin D supplementation on antibiotic use: a randomized controlled trial. Am J Clin Nutr (2013) 0.93
The effect of acute exercise on undercarboxylated osteocalcin and insulin sensitivity in obese men. J Bone Miner Res (2014) 0.93
Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adults. J Clin Endocrinol Metab (2014) 0.93
The relationship between body composition and knee cartilage volume in healthy, middle-aged subjects. Arthritis Rheum (2005) 0.92
Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome. Arterioscler Thromb Vasc Biol (2012) 0.92
Resting B cells suppress tumor immunity via an MHC class-II dependent mechanism. J Immunother (2007) 0.92
Injection-locking of terahertz quantum cascade lasers up to 35GHz using RF amplitude modulation. Opt Express (2010) 0.92
Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies. Cell Stem Cell (2013) 0.91
Contrasting effects of P-selectin and E-selectin on the differentiation of murine hematopoietic progenitor cells. Exp Hematol (2005) 0.91
Biology and clinical observations of regulatory T cells in cancer immunology. Curr Top Microbiol Immunol (2011) 0.91
Vitamin D deficiency and its role in muscle-bone interactions in the elderly. Curr Osteoporos Rep (2014) 0.91
Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. J Clin Endocrinol Metab (2015) 0.90
Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains. Br J Haematol (2013) 0.90
Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. J Clin Oncol (2009) 0.90
Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation. Virchows Arch (2009) 0.90
Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome. Haematologica (2007) 0.89
Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Leuk Lymphoma (2012) 0.89
Osteo-cise: strong bones for life: protocol for a community-based randomised controlled trial of a multi-modal exercise and osteoporosis education program for older adults at risk of falls and fractures. BMC Musculoskelet Disord (2012) 0.89
Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting. Med J Aust (2010) 0.89
An oxysterol-binding protein family identified in the mouse. DNA Cell Biol (2002) 0.89
Tophaceous gout of the patella: a report of two cases. Case Rep Rheumatol (2012) 0.88
The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study. Osteoporos Int (2004) 0.88
Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults. Obesity (Silver Spring) (2014) 0.88
Declining incidence of osteoporotic hip fracture in Australia. Arch Osteoporos (2012) 0.88